Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism

Background. In patients with pulmonary hypertension, it is unknown whether the treatment effect of bosentan is dependent on the duration of pulmonary vessel changes. Therefore, we studied the response to bosentan in patients with life-long pulmonary vessel changes (pulmonary arterial hypertension (P...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Duffels, M.G.J., van der Plas, M.N., Surie, S., Winter, M.M., Bouma, B., Groenink, M., van Dijk, A.P.J., Hoendermis, E., Berger, R.M.F., Bresser, P., Mulder, B.J.M.
Format: Artigo
Langue:Inglês
Publié: Bohn Stafleu van Loghum 2009
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2758348/
https://ncbi.nlm.nih.gov/pubmed/19949475
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires